BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report)’s stock price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.97 and traded as low as $1.68. BioRestorative Therapies shares last traded at $1.76, with a volume of 36,331 shares trading hands.
BioRestorative Therapies Stock Performance
The firm has a market cap of $12.18 million, a price-to-earnings ratio of -1.15 and a beta of 64.37. The company’s fifty day moving average is $1.97 and its two-hundred day moving average is $1.71.
About BioRestorative Therapies
BioRestorative Therapies, Inc engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company’s initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- What is the NASDAQ Stock Exchange?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Why is the Ex-Dividend Date Significant to Investors?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
